《大行報告》瑞銀上調太平(00966.HK)目標價至19.5元 評級「買入」
瑞銀發表研究報告,指中國太平(00966.HK)1月壽險業務原保險保費收入按年升近4%至369億元人民幣,意味1月首年保費收入按年增長逾60%;瑞銀認為這優於市場預期,現估值尚未反映新業務價值增長。由於基數較低,瑞銀預期太平2月及3月份的首年保費表現續強勁,升今年新業務價值增長預測,由14%上調至16%,以反映1月表現,目標價由18.6元升至19.5元,評級「買入」。
該行同時指,行業「開門紅」表現各異,中國太保(02601.HK)及中國平安(02318.HK)由於較早開始準備「開門紅」,自去年10月起錄高雙位數增長;由於基數較高,據瑞銀以1月數據估算,新華保險(01336.HK)首年保費表現則較同業為弱。該行列出所覆蓋內地壽險股新業務價值全年增長預測,平安料12%,太保料14%,新華保險料5%,中國人壽(2628.HK)則料13%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.